相似文献
1
High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad, and the Future II.
Biomedicines. 2022 Mar 7;10(3):620. doi: 10.3390/biomedicines10030620.
2
Current Therapies Focused on High-Density Lipoproteins Associated with Cardiovascular Disease.
Molecules. 2018 Oct 23;23(11):2730. doi: 10.3390/molecules23112730.
3
High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad, and the Future.
Int J Mol Sci. 2021 Jul 13;22(14):7488. doi: 10.3390/ijms22147488.
4
High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad and the Future.
Biomedicines. 2021 Jul 22;9(8):857. doi: 10.3390/biomedicines9080857.
5
[The biological activity of high-density lipoprotein fractions and their role in the development of cardiovascular diseases].
Ter Arkh. 2016;88(9):111-118. doi: 10.17116/terarkh2016889111-118.
6
Native high density lipoproteins (HDL) interfere with platelet activation induced by oxidized low density lipoproteins (OxLDL).
Int J Mol Sci. 2013 May 10;14(5):10107-21. doi: 10.3390/ijms140510107.
7
Beginning to understand high-density lipoproteins.
Endocrinol Metab Clin North Am. 2014 Dec;43(4):913-47. doi: 10.1016/j.ecl.2014.08.001.
8
Antiatherogenic functionality of high density lipoprotein: how much versus how good.
J Atheroscler Thromb. 2008 Apr;15(2):52-62. doi: 10.5551/jat.e571. Epub 2008 Apr 3.
9
Subfractions and subpopulations of HDL: an update.
Curr Med Chem. 2014;21(25):2881-91. doi: 10.2174/0929867321666140414103455.
10
Targeting high-density lipoproteins: update on a promising therapy.
Arch Cardiovasc Dis. 2013 Nov;106(11):601-11. doi: 10.1016/j.acvd.2013.06.052. Epub 2013 Sep 25.
引用本文的文献
1
Excessive Consumption of Alcoholic Beverages and Extremely High Levels of High-Density Lipoprotein Cholesterol (HALP) in the ELSA-Brasil Cohort Baseline.
Nutrients. 2023 Feb 28;15(5):1221. doi: 10.3390/nu15051221.
本文引用的文献
1
HDL Is Not Dead Yet.
Biomedicines. 2022 Jan 7;10(1):128. doi: 10.3390/biomedicines10010128.
2
The Capacity of APOB-Depleted Plasma in Inducing ATP-Binding Cassette A1/G1-Mediated Macrophage Cholesterol Efflux-But Not Gut Microbial-Derived Metabolites-Is Independently Associated with Mortality in Patients with ST-Segment Elevation Myocardial Infarction.
Biomedicines. 2021 Sep 27;9(10):1336. doi: 10.3390/biomedicines9101336.
3
Apolipoprotein Signature of HDL and LDL from Atherosclerotic Patients in Relation with Carotid Plaque Typology: A Preliminary Report.
Biomedicines. 2021 Sep 3;9(9):1156. doi: 10.3390/biomedicines9091156.
4
High-Density Lipoprotein Subfractions: Much Ado about Nothing or Clinically Important?
Biomedicines. 2021 Jul 18;9(7):836. doi: 10.3390/biomedicines9070836.
5
Familial Hypercholesterolemia: Do HDL Play a Role?
Biomedicines. 2021 Jul 13;9(7):810. doi: 10.3390/biomedicines9070810.
6
HDL Dysfunctionality: Clinical Relevance of Quality Rather Than Quantity.
Biomedicines. 2021 Jun 25;9(7):729. doi: 10.3390/biomedicines9070729.
7
Structure and Dynamics of Oxidized Lipoproteins In Vivo: Roles of High-Density Lipoprotein.
Biomedicines. 2021 Jun 8;9(6):655. doi: 10.3390/biomedicines9060655.
8
HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research.
Circulation. 2021 Jun 8;143(23):2293-2309. doi: 10.1161/CIRCULATIONAHA.120.044221. Epub 2021 Jun 7.
9
Subpopulations of High-Density Lipoprotein: Friends or Foes in Cardiovascular Disease Risk in Chronic Kidney Disease?
Biomedicines. 2021 May 16;9(5):554. doi: 10.3390/biomedicines9050554.
10
Fetal High-Density Lipoproteins: Current Knowledge on Particle Metabolism, Composition and Function in Health and Disease.
Biomedicines. 2021 Mar 30;9(4):349. doi: 10.3390/biomedicines9040349.
Zotero 插件